Tirzepatide insurance, HSA and FSA guide
Who pays for tirzepatide depends on the product, the indication and your specific plan. This guide separates the cases so you can stop guessing.
Compounded tirzepatide is almost always cash-pay: insurers cover FDA-approved products, not compounded ones. HSA and FSA funds can generally be used for a prescribed medication and the visits tied to it; keep the prescription and itemized receipts and confirm with your plan administrator. Brand Zepbound coverage is plan-specific and usually requires prior authorization.
What each payment source will and will not do
| Payment source | Compounded tirzepatide | Brand Zepbound / Mounjaro | What to check |
|---|---|---|---|
| Commercial insurance | Rarely covered; compounded drugs are typically excluded | Plan-specific. Many plans exclude weight-management drugs entirely; those that cover Zepbound usually require prior authorization. Mounjaro for type 2 diabetes is more often covered | Your plan’s formulary and exclusions, not a general rule |
| Medicare Part D | Not covered | Drugs used for weight loss are excluded by statute; coverage can exist for a separate approved indication (Mounjaro for type 2 diabetes; Zepbound for obstructive sleep apnea with obesity). Medicare guide | The indication on the prescription and the plan’s formulary |
| Medicaid | Not covered | Varies by state program and preferred drug list; many states cover for diabetes only | Your state program’s current preferred drug list |
| HSA | Generally eligible when prescribed for a diagnosed condition | Eligible | Keep the prescription, itemized receipt and, if asked, a letter of medical necessity |
| FSA | Generally eligible as above; some administrators ask for documentation | Eligible | Your administrator’s substantiation rules; plan-year deadlines |
| Manufacturer savings card | Not applicable | Lilly’s programs apply to brand products and generally exclude government insurance. Zepbound savings guide | Current terms on Lilly’s site |
Using an HSA or FSA for a compounded program
IRS rules treat prescribed medicines and medical care for a diagnosed condition as qualified medical expenses (IRS Publication 502, Medical and Dental Expenses). A telehealth program bundles several things: the medication, clinician visits, sometimes labs, and sometimes a membership fee. The medication and visits are generally eligible; a membership fee is eligible only to the extent it pays for medical care. Ask the provider for an itemized receipt that separates those items, and ask your administrator before you rely on it. Some administrators request a letter of medical necessity for weight-management treatment; a diagnosis of obesity or a weight-related condition documented by the prescriber usually satisfies it.
Why cash price comparisons matter more here
Because compounded programs are cash-pay, the 12-month total at your maintenance dose is the number to compare, not a starter price. Our cost guide and calculator do that math with dated prices; the cost without insurance guide covers the brand alternatives.
Before assuming you will pay cash
- If you have type 2 diabetes, ask your prescriber about Mounjaro® through your plan first; coverage is more common and a copay can be far below any cash program.
- If your plan covers Zepbound® with prior authorization, the paperwork is usually worth a week of waiting.
- If you are paying cash for the approved product, compare LillyDirect’s dose-specific vial prices with compounded programs at the same dose (brand vs compounded comparison).
Frequently asked questions
Generally yes for a prescribed medication and the clinician visits tied to it, whether brand or compounded, when treatment is for a diagnosed condition. Keep the prescription and itemized receipts. Administrators differ on documentation, so confirm before you pay.
Almost never. Insurers and government programs cover FDA-approved products; compounded preparations are usually excluded outright. Treat compounded programs as cash-pay and compare their all-in cost.
Part D plans cannot cover drugs used for weight loss, but can cover Zepbound prescribed for obstructive sleep apnea with obesity, and Mounjaro for type 2 diabetes, subject to the plan’s formulary. Rules and plan lists change; verify with the plan.
Not always. Some FSA administrators request one for weight-management treatment. The prescriber can provide a short letter stating the diagnosis and that the medication is prescribed to treat it.
Primary sources
Change log
Substantive changes to this page are logged so readers and AI systems can judge how current it is.
| Date | Change |
|---|---|
| August 26, 2026 | Page created. Replaces generalized state-level insurance statements with plan-specific guidance. |